Halo™, the world’s first Hybrid Fractional Laser (HFL), is revolutionizing resurfacing. Halo delivers non-ablative and ablative wavelengths to the same microscopic treatment zone, giving patients results they love without the discomfort or downtime they expect.
Halo, the world’s first hybrid fractional laser, applies tunable non-ablative (1470nm) and ablative (2940nm) wavelengths to the same microscopic treatment zone to maximize results and reduce downtime. Sciton’s new technology produces targeted, reproducible, effective results that improve the appearance of numerous skin conditions. Intelligent energy delivery, combined with Dynamic Thermal Optimization, ensures precise, even, safe treatments. Halo owners love achieving maximum return on their investment while exceeding their patients’ expectations. Easy to use and virtually painless, Halo sets the standard for the future of laser resurfacing by providing a safe and powerful long-term hybrid solution. As part of the multifaceted, expandable JOULE platform, Halo provides the practitioner with a dynamic and essential component of their aesthetic toolbox.
Long term sun exposure, active lifestyle and the wear and tear of everyday living results in visible signs of skin aging, including wrinkles, discoloration, scars and laxity. A fractional treatment, whether ablative or coagulative, allows the epidermis to heal quickly as long as the dermis remains intact. Ablative fractional resurfacing is a well-established treatment that vaporizes aged tissue with less thermal injury, with mild to moderate levels of morbidity and downtime. Conversely, non-ablative fractional resurfacing causes thermal injury and tissue coagulation with lower levels of morbidity. The HALO hybrid fractional laser combines ablative and non-ablative wavelengths delivered to the same microscopic treatment zone to maximize clinical results and minimize downtimes. HALO is safe and effective, while providing an enhanced patient experience.
Halo provides unique benefits including:
- Ability to treat pores using ablative and non-ablative wavelengths
- Results in just 1-2 treatments vs. 3-5 traditional resurfacing treatments
- Lower consumable cost vs. leading competitor
- More comfortable than traditional fractional resurfacing (no nerve blocks needed)
- Faster healing time Easy to perform and safe to delegate
Patients treated with HALO experience great improvement to the appearance of texture and pigment. They can expect amazing results in 1-2 treatments while older, non-hybrid technology often requires 5-6 treatments to demonstrate similar texture changes without approaching Halo in terms of pigment correction. The HALO patient experience is second-to-none: the treatment is extremely comfortable, only a topical anesthetic is recommended (no nerve blocks), and patients can apply makeup within 24 hours of the procedure.
Primary treatments include:
- Sun Damage/Dyschromia
- Signs of Aging
- Improve the appearance of Enlarged Pores
- Improve the appearance of Fines Lines
- Poor Texture
- Improve the appearance of Light Scars
- Uneven Tone
HALO can treat most skin types, on face and body. Popular off-face treatments include: neck, chest, arms, hands, legs and scarring.
HALO by Sciton sets the standard for the future of laser resurfacing by providing a safe, tunable, and effective long-term hybrid option for resurfacing treatments.
Science + Technology
Adding tunable ablation to a non-ablative treatment creates varying effects when different levels are used. Low levels of ablation (up to 20 microns) cause faster clearance of microscopic epidermal necrotic debris (MENDs). Heavier levels of ablation (up to 100 microns) seem to create a synergistic wound healing response. The clinical effect is ablative-like results with nearly non-ablative-like healing.
Figure 3. HALO A) before and B) after 2 treatments | 1470 mm: 425 μm, 45%; 2940 nm: 50 μm, 30% Courtesy of Santuary Medical Center
- The 2940 nm wavelength targets the epidermis or top layer of the skin
(20-100um) and ablates tiny columns addressing textural issues and pores
- The 1470 nm wavelength targets the dermis to address deeper sun damage and other dermal pigmentary issues (100-700um) as well as stimulate collagenesis
- Each wavelength can be tuned independently for precise coverage and depth
Beyond the hybrid technology that makes Halo so unique are many features that help improve usability and safety. Features include:
- Tunable 1470 nm depth
- Dynamic Thermal Optimization technology
- Intelligent energy-based parameters
- Platform approach
HALO offers the flexibility of completely turning off ablation for users that are not qualified to use an ablative laser or for those looking for the simplest laser treatments. Both the ablative and non-ablative laser wavelengths can be delivered in the same pass, and many different permutations of depths and coverage are possible.
Halo’s Physician Interface
Mechanism of Action
Adding tunable ablation to a non-ablative treatment creates varying effects when different levels are used. Using low levels of ablation (up to 20 microns) causes faster clearance of microscopic epidermal necrotic debris (MENDs). Heavier levels of ablation (up to 100 microns) seem to create a synergistic wound healing response. The clinical effect is ablative-like results with nearly non-ablative-like healing.
During a non-ablative treatment, a column of the skin (MTZ) is heated to a temperature that necroses the epidermis and denatures dermal collagen. In the first 24 hours, the basal cell layer regenerates across the MTZs, under the necrosed epidermis, and then proliferates upwards, expelling the necrosed tissue. This necrosed tissue becomes small packets of debris (MENDs) that are trapped under the stratum corneum, taking between 2 to 7 to days to clear. Performing a 20 micron ablation followed by coagulation allows faster removal of MENDs. By removing the stratum corneum, the MENDs are free to exit the skin within a day of forming. This results in 1 – 2 days faster healing time as compared to non-ablative treatments.
Ablating tissue creates a stronger wound healing response than just coagulating the tissue2. This wound healing response can be leveraged by adding more ablation during a Halo treatment. Adding up to 100 microns of ablation removes some of the tissue that would otherwise be necrosed near the surface, eliminating any MEND formation and limiting adverse events near the surface. In addition, the increased wound healing response in ablated tissue has a synergistic effect when combined with coagulated tissue though activation of Activator Protein 1 (AP-1) transcription factor leading to upregulation of Matrix Metalloproteinase (MMPs)
which drive dermal remodeling3. The combination of the ablated epidermis’ inflammatory response with the denaturing of the dermis’ collagen probably accounts for the greater, ablative-like results that are seen with a hybrid fractional treatment.